Results

Total Results: 1,991 records

Showing results for "participants".

181. Outcomes of Angiotensin-converting Enzyme Inhibitor (ACEI) Use During Pregnancy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/pregnancy-acei-outcomes/abstract
     April 14, 2010 - Participants Pregnant women and their live born offspring (465?

182. Nitrous Oxide for the Management of Labor Pain | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/labor-nitrous-oxide/research
     August 23, 2012 - excluded studies that did not address a Key Question, were not original research, or had fewer than 20 participants

183. Developing Quality Indicators for Cancer End-of-Life Care: Proceedings From a National Symposium | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-end-of-life-indicators-symposium/research
     September 08, 2010 - Methods Symposium participants were divided into multidisciplinary groups to address the identified … breakout sessions, groups presented a summary of their priority issues and solutions to all symposium participants … For areas with more indicator development, participants felt that there had been sufficient development … The issue of ideal sources of information was also difficult to resolve, as participants identified strengths … Participants did agree on a number of challenges that remain across domains.

184. Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
     July 10, 2018 - In many cases, determining whether participants met criteria for PTSD, or other related disorders such … Number of enrolled participants k. Diagnostic instrument(s) l. … Number of enrolled participants as well as the number of participants randomized to each study arm … Number of participants who completed the treatment b. … Number of participants who completed measurement for primary PTSD outcome measure at each time point

185. Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
     July 10, 2018 - In many cases, determining whether participants met criteria for PTSD, or other related disorders such … Number of enrolled participants k. Diagnostic instrument(s) l. … Number of enrolled participants as well as the number of participants randomized to each study arm … Number of participants who completed the treatment b. … Number of participants who completed measurement for primary PTSD outcome measure at each time point

186. Insomnia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
     December 01, 2015 - Participants often had comorbidities. … The mean age of participants was typically in the mid-40s, participants were predominantly female, … Those that enrolled only older adults randomized participants to low doses of the drug. … High proportions of participants in treatment and placebo groups reported adverse effects. … Participants met specific diagnostic criteria for insomnia disorder (or chronic insomnia).

187. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol
     December 21, 2010 - Population KQs 1–4 Adult participants (the majority of participants ≥16 years of age or with subgroup … Where more than one cardiovascular drug is taken by study participants (e.g., where drugs are generally … KQ 5 Adult participants (the majority ≥16 years of age or with subgroup data presented for adults). … KQ 5 In addition to the above, uncontrolled before and after studies with at least five participants … at risk for cardiovascular disease, with known cardiovascular disease; participants with diabetes; participants

188. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
     December 15, 2010 - (the majority of participants ≥16 years of age or with subgroup data presented for adults) taking at … Where more than one cardiovascular drug is taken by study participants (e.g., where drugs are generally … KQ 5 In addition to the above, uncontrolled before and after studies with at least five participants … at risk for cardiovascular disease, with known cardiovascular disease; participants with diabetes; … participants with hepatic or renal dysfunction or end-stage renal disease; participants taking a cardiovascular

189. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
     December 20, 2011 - Were the participants in the case group representative of the case definition? 3. … Were the participants in the control group representative of the control definition? … Did the authors clearly describe the population from which the participants were drawn? 2. … Did the authors clearly describe the population from which the participants were drawn? 2. … Did the authors clearly describe the population from which the participants were drawn? 2.

190. Renal-Artery-Stenosis Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
     June 01, 2012 - The sample size of the observational studies ranged from 40 13 to 149 5 participants. … The majority of the participants in these reports were male ranging from 23% 5 to 76% 11. 3.2.2 … Renal artery 31 Author year Study name (if applicable) Study design participants … 33 Author year Study name (if applicable) Study design participants Intervention groups … stenting Complications: 34 Author year Study name (if applicable) Study design participants

191. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - than among placebo participants. … than for placebo participants. … High Participants who took raloxifene showed higher odds for pulmonary embolism than did participants … Raloxifene participants also had greater odds of thromboembolic events. … (CVA) and thromboembolic events than did placebo participants.

192. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/module_ii1.ppt
     June 01, 2011 - . * Module II Learning Objectives After completing Module II, participants will be able to: Define … in EHC Program research Describe strategies for engaging stakeholders After completing Module II, participants … Participants vote on top priorities. a) Receive b) React c) Participate d) Engage 3) A Congressperson … Participants vote on top priorities. a) Receive b) React c) Participate d) Engage 3) A Congressperson … Stakeholders may be engaged throughout the research process in different ways; as key informants, as participants

193. Using Deliberative Methods to Engage the Public: How to Design and Implement an Effective Deliberative Session (Video Presentation) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/deliberative-methods/presentation-2012
     April 19, 2012 - Recruiting/Selecting Participants by Susan Dorr Goold in slide presentation (PDF, 116 kB) and text … Educating Session Participants by Susan Dorr Goold in slide presentation (PDF, 130 kB) or text (

194. Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
     December 31, 2022 - selection bias could arise from the data sources used to identify eligible individuals or the ways participants … Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure … (participants without antecedent of SARS-CoV-2 infection) Group 2: Previously SARS CoV-2 infected … participants (participants with antecedent of SARS-CoV-2 infection [more than 6 months]) IgG humoral … : Parents or guardians of participants in all cohorts will also be enrolled for limited participation

195. App-D-Surv-Report-2-Noninvasive-Nonpharma 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma_0.xlsx
     January 01, 2022 - Maximum of 13 participants per group. … Maximum of 13 participants per group. … Participants from both groups were encouraged to perform a daily 20 minute home training. A vs. … Participants recieved general health education information and facts related to OA. … Participants were instructed to relax for 8 minutes while B.

196. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
     January 01, 2022 - Maximum of 13 participants per group. … Maximum of 13 participants per group. … Participants from both groups were encouraged to perform a daily 20 minute home training. A vs. … Participants recieved general health education information and facts related to OA. … Participants were instructed to relax for 8 minutes while B.

197. Infantile-Hemangioma Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
     January 01, 2016 - Another study found the likelihood of laser treatment was lower in participants treated with propranolol … than participants who did not receive the medication. … Most comparative studies were small (≤55 participants), but one RCT and three retrospective cohort studies … Another study found the likelihood of subsequent laser treatment was lower in participants treated … with propranolol than participants who received other treatments.

198. Executive Summary_Comparative Effectiveness Review No. 261_Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-261-postpartum-care-executive-summary.pdf
     June 01, 2023 - Results We found 92 primary studies comprising 3,967,261 participants in total. … The 92 studies included 50 RCTs (N = 477,954 participants) and 42 NRCSs (i.e., observational studies … that compared 2 or more interventions; N = 3,489,307 participants). … Moreover, most of the studies did not report information by subgroups of participants who may be vulnerable

199. Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/copd-management/research
     December 04, 2009 - Participants Patients with a diagnosis of chronic obstructive pulmonary disease that were 45 years

200. Protocol for Quantitative Assessment of Benefit and Harm analysis of Aspirin for primary prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research.pdf
     February 01, 2014 - with an event over a particular period of time divided by all participants that the study observed) … We selected a study that measured the preferences of participants that had not experienced these events … health outcomes with aspirin for primary prevention using a visual analog scale.13 The participants … , we did not consider the variability of assigned relative weights across participants. … Some trials excluded subjects with prior GI bleeds and thus minimized the risk for trial participants